Reshape Lifesciences Inc. buy PlusUltra
Start price
02.12.20
/
50%
€141.75
Target price
02.12.21
-
Performance (%)
-50.05%
End price
03.12.21
€70.80
Summary
This prediction ended on 03.12.21 with a price of €70.80. Massive losses of -50.05% were the result for the BUY prediction by PlusUltra. PlusUltra has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Reshape Lifesciences Inc. | - | - | - | - |
iShares Core DAX® | 1.665% | 1.692% | 18.093% | 15.353% |
iShares Nasdaq 100 | -0.475% | 1.483% | 27.860% | 36.314% |
iShares Nikkei 225® | 2.620% | 4.475% | 17.651% | 10.750% |
iShares S&P 500 | -0.091% | 1.099% | 24.873% | 36.740% |
Comments by PlusUltra for this prediction
In the thread Discuss Obalon Therapeutics Inc.
Buy Obalon Therapeutics Inc.
In the thread Trading ReShape Lifesciences Inc.
Die von PlusUltra gewählte maximale Laufzeit wurde überschritten